NewsRx

Search our medical news database

Vector Development

Non-Viral Polycation-Based Vector Delivers to CD4+ Cells

Published in AIDS Weekly, November 22nd, 1999

A non-viral, polycation-based vector may provide a means of delivering anti-HIV gene therapies to CD4+ cells, suggests research from Australia.

"CD4- selective targeting of an antibody-polycation-DNA complex was investigated," stated R.L. Puls and colleagues from the University Western Australia ("Gene Transfer and Expression of a Non-Viral Polycation-Based Vector in CD4+ Cells," Gene Therapy, October 1999;6(10):1774-1778).

The researchers synthesized the complex with the anti-CD4 monoclonal antibody B-F5, polylysine(268) (pLL), and either the pGL3 control vector containing the luciferase reporter gene or the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook